Users Online: 4414
Home Print this page Email this page
Home About us Editorial board Search Browse articles Submit article Ahead of Print Instructions Subscribe Contacts Login

     Instructions to the Authors


Submission Guidelines

The Journal of Advanced Biomedical Research (ABR), a publication of Isfahan University of Medical Sciences, is an open access, peer-reviewed journal that publishes high-quality articles, in English, in areas related to medicine and biology, including basic science research and clinical investigations that reach a conclusion of interest to an interdisciplinary readership. 

This page includes information about preparing a manuscript for submission to ABR, criteria for publication, and the online submission process. We recommend that you take the time to read them before submitting a contribution to ABR. Other relevant information about the journal can be found in 'About journal.'



Before you submit

1- Make sure that the journal is suitable for your manuscript. To ensure, please read the aims and scopes of the journal.

2- Know about the indexing and abstracting of our journal.

3- Know about the type of articles we publish.

4- Know about the open access policy and costs of publishing.

5-  Understand the Standards of reporting.

6- Make sure your manuscript is of sufficient quality to be understood- Language Editing Services


Ready to submit

1- Agree to conditions of submission.

2- Read and agree to our editorial policies.

3- Prepare your manuscript according to the General formatting guidelines and also based on our article types.


Submit and afterward

1- Submit your manuscript through our online submission platform.

2- What are the Editorial Process and Peer-review policy of the journal, and how does ABR decide whether my work will be accepted?



Before you submit

1- Make sure that the journal is suitable for your manuscript. To ensure, please read the aims and scopes of the journal:

Aims and Scopes:

The journal features work of significance in all areas related to medicine and biology, including basic science research and clinical investigations. We encourage the submission of manuscripts that cross disciplines and studies that address universal human health problems.


Basic Sciences:

ABR will encompass:

  • Anatomy
  • Immunology
  • Animal models
  • Microbiology
  • Cell and Molecular Biology
  • Parasitology
  • Cell and Tissue Research
  • Pathology
  • Cellular Biochemistry
  • Pharmacology
  • Cytology
  • Physiology
  • Histology

 

Interdisciplinary and multi-disciplinary :

 ABR will publish researches on biomedical disciplines, including:

  • bioinformatics
  • medical imaging
  • genomics
  • nanotechnology
  • proteomics
  • neuroscience

Clinical Sciences: 

ABR will publish researches across a broad scope of medical disciplines, including:

  • Anesthesiology
  • Neurology
  • Cardiovascular
  • Nutrition
  • Complementary and alternative medicine
  • Obstetrics and gynecology
  • Critical care and emergency medicine
  • Oncology
  • Dermatology
  • Ophthalmology
  • Endocrinology
  • Otorhinolaryngology
  • Gastroenterology and hepatology
  • Pediatrics
  • Genetics
  • Public Health
  • Geriatrics
  • Pulmonology
  • Hematology
  • Radiology
  • Immunology
  • Rheumatology
  • Infectious Diseases
  • Sports and exercise medicine
  • Mental health
  • Surgery
  • Metabolic disorders
  • Toxicology
  • Nephrology
  • Urology
  • Neurology
 

2- Know about the indexing and abstracting of our journal:

Indexing and Abstracting:

Advanced Biomedical Research is indexed in:

PubMed Central (PMC), Web of Science Emerging: Sources Citation Index [ISI(ESCI)], Directory of Open Access Journals (DOAJ), Scopus

 ESCI Pubmed Pubmed Central DOAJ


3- Know about the type of articles we publish; please read the Article types below.

Article Types:

Original articles:

These include randomized controlled trials, intervention studies, studies of screening and diagnostic tests, outcome studies, cost-effectiveness analyses, case-control series, and surveys with high response rates.

  • The text of original articles amounting to up to 3000 words, including the abstract(250 words), references, figures, and tables.
  • The number of tables and figures for this type of article should be up to 5.
  • Original articles could be supported with up to 40 references.

For the detailed formatting guideline for original articles, please click here.

Review Articles:

It is expected that these articles would be written by individuals who have done substantial work on the subject or are considered experts in the field. A summary of the work done by the contributor(s) in the field of review should accompany the manuscript.

  • The prescribed word count is up to 7000 words, including tables/figures, references, and abstract.
  • The manuscript may have unlimited references.
  • The manuscript should have an unstructured abstract (250 words) representing an accurate article summary.

For the detailed formatting guideline for review articles, please click here.

Short Reports/Communications:

 Short reports provide a brief but complete account of an original piece of work.

  • The manuscript could be up to 1000 words (including references and abstract).
  • The manuscript could be supported with up to 15 references.
  • The manuscript should have a structured Abstract (200 words) representing an accurate article summary.

For the detailed formatting guideline for short reports, please click here.

Case reports:

New, interesting, and rare cases can be reported. They should be unique, describing a great diagnostic or therapeutic challenge and providing a learning point for the readers. Cases with clinical significance or implications will be given priority.

  • The manuscript could be up to 1000 words (including references and abstract).
  • The manuscript could be supported with up to 15 references.
  • Case Reports could be authored by up to four authors.

For the detailed formatting guidelines for case reports, please click here.

Letter to the Editor:

A Letter to the Editor generally takes one of the following forms:

  • A substantial re-analysis of a previously published article in Advanced Biomedical Research or in another journal.
  • An article that may not cover "standard research" but that is of general interest to the readership of Advanced Biomedical Research.
  • A brief report of research findings adequate for the journal's scope and of particular interest to the community.
  • The letter could have up to 500 words and 7 references.
  • Not more than four authors could generally author it.

For the detailed formatting guidelines for Letter to Editor, please click here.

Other:

Editorial, Guest Editorial, Commentary, and Opinion are solicited by the editorial board.


4- Know about the open access policy and publishing costs; please read the Article-processing charge below.

Open access:

All articles published by ABR are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers.

Article Processing Fee:

ABR is an open-access journal; Open access publishing is not without costs. ABR, therefore, levies an Article Processing Fee (APF) for each article accepted for publication. The APF is payable upon acceptance through our submission platform.

Article Type Word Limit Max Number of Tables and Figures Article Processing Fee Extra Payment per 700 Words
Original Article 3000 5 300$ 50$
Review Article 7000 Unlimited 300$ 50$
Short Report 1000 2 150$ 50$
Case Report 1000 5 150$ 50$
Letter to Editor 500 1 Free -

For Iranian authors, because of sanctions and money transfer problems, the journal also accepts the Iranian Rial (IRR). The APF is payable upon acceptance through an internet gateway.

Article Type Word Limit Max Number of Tables and Figures Article Processing Fee Extra Payment per 700 Words
Original Article 3000 5 8,000,000 IRR 1,500,000 IRR
Review Article 7000 Unlimited 8,000,000 IRR 1,500,000 IRR
Short Report 1000 2 4,000,000 IRR 1,500,000 IRR
Case Report 1000 5 4,000,000 IRR 1,500,000 IRR
Letter to Editor 500 1 Free -

 

APF can be waived, and only in exceptional circumstances. Please contact the editor BEFORE submission to get an informal opinion on whether or not a particular paper/topic may get sufficient priority for an APF waiver. You will also need to fill in an application form, signed by ALL coauthors and their department heads, confirming that no other funds are available. The application form with all signatures of all co-authors and their department chairs should be made on submission (upload a scanned document as supplementary file).


5-  Understand the Standards of reporting.

Standards of Reporting:

ABR advocates complete and transparent reporting of biomedical and biological research. For biomedical and biological research, the checklist below must be completed before peer review and made available to the Editors and reviewers.

  • Randomized controlled trials (CONSORT)
  • Case reports (CARE)

We strongly recommend that authors refer to the minimum reporting guidelines for health research hosted by the EQUATOR Network when preparing their manuscript and FAIRsharing.org for reporting checklists for biological and biomedical research, where applicable. 

In addition, ABR strongly encourages the use of the following checklists and reporting guidelines:

  • Protocols for randomized controlled protocols (SPIRIT)
  • Systematic reviews and meta-analyses* (PRISMA) and protocols (PRISMA-P)
  • Observational studies (STROBE)
  • Qualitative research (COREQ)
  • Diagnostic/prognostic studies (STARD and TRIPOD)
  • Pre-clinical animal studies (ARRIVE)

Language Editing Services:

For editors and reviewers to accurately assess the work presented in your manuscript,t you need to ensure the English language is of sufficient quality to be understood.

Authors who are not native speakers of English who submit manuscripts to international journals often receive negative comments from referees or editors about the English–language usage in their manuscripts. These problems can contribute to a decision to reject a paper. To help reduce the possibility of such issues, we strongly encourage such authors cotoconsiderr using Wolters Kluwer Author Services.

Wolters Kluwer Author Services

In partnership with Editage, Wolters Kluwer offers a unique range of editorial services to help you prepare a submission-ready manuscript. For more information regarding Wolters Kluwer Author Services, please visit http://wkauthorservices.editage.com.

Note that the use of such a service is at the author's own expense and risk and does not guarantee that the article will be accepted.



Ready to submit

1- Agree to conditions of submission.

Copyright and license agreement:

During submission, you will need to accept and confirm the following conditions:

  • All authors of the manuscript have read and agreed to its content and are accountable for all aspects of the accuracy and integrity of the manuscript in accordance with ICMJE criteria.
  • That the article is original, has not already been published in a journal, and is not currently under consideration by another journal
  • That you agree to the terms of the Copyright and License Agreement, which we strongly recommend you read

For more information, see our Copyrights.

Article Processing Fee:

An article-processing fee(APF) applies for each article accepted for publication in ABR. For further details, please see our APF section.


2- Read and agree to our editorial policies.

Editorial Policies:

Ethics Policy:

The editors and staff of ABR adhere to the ethical standards established by the Committee on Publication Ethics (COPE) and are committed to providing authors with a transparent process in the handling of manuscripts received in the editorial office. 

In addition, ABR follows the guidance on editorial independence produced by the World Association of Medical Editors and subscribes to the tenets of reporting guidelines established by the EQUATOR network. ABR supports the policies of the International Committee of Medical Journal Editors (ICMJE), and the following author's instructions follow the ICMJE Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Manuscript preparation should follow these ICMJE guidelines.

Ethics:

When reporting studies on human beings, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Declaration of Helsinki of 1975, as revised in 2013 (available at https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/). For prospective studies involving human participants, authors are expected to mention the approval of (regional/ national/ institutional or independent Ethics Committee or Review Board, obtaining informed consent from adult research participants, and obtaining assent for children over 7 years participating in the trial. The age beyond which assent would be required could vary as per regional and/ or national guidelines. Ensure confidentiality of subjects by desisting from mentioning participants’ names, initials, or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institutions or a national research council’s guide for or any national law on the care and use of laboratory animals was followed.

Evidence for approval by a local Ethics Committee (for both human as well as animal studies) must be supplied by the authors on demand. Animal experimental procedures should be as humane as possible, and the details of anesthetics and analgesics used should be clearly stated. The ethical standards of experiments must be in accordance with the guidelines provided by the CPCSEA and World Medical Association Declaration of Helsinki on Ethical Principles for Medical Research Involving Humans for studies involving experimental animals and human beings, respectively). The journal will not consider any paper which is ethically unacceptable. A statement on ethics committee permission and ethical practices must be included in all research articles under the ‘Materials and Methods section.

Copyrights:

The entire contents of Advnced Biomedical Research journal are protected under Indian and international copyrights. The Journal, however, grants to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, perform and display the work publicly and to make and distribute derivative works in any digital medium for any reasonable non-commercial purpose, subject to proper attribution of authorship and ownership of the rights. The journal also grants the right to make small numbers of printed copies for their personal non-commercial use under Creative Commons Attribution-Noncommercial-Share Alike 4.0 International Public License.

Preprints:

ABR has no objections to considering preprints for publication. If an author is submitting a manuscript that has been shared as a preprint, authors should include the preprint server name and DOI on the title page.

Authorship Criteria:

Authorship credit should be based only on substantial contributions to each of the three components mentioned below, and it should be stated on the first page:

  • Concept and design of study or acquisition of data or analysis and interpretation of data
  • Drafting the article or revising it critically for important intellectual content
  • Final approval of the version to be published

It should be noted that:

  • Honorary or guest authorship is not acceptable.
  • Co-corresponding authorship is acceptable.
  • Co-first authorship is not acceptable.
  • Acquisition of funding and provision of technical services, patients, or materials, while they may be essential to the work, are not in themselves sufficient contributions to justify authorship.

The authors confirm contribution to the paper as follows: study conception and design: X. Author, Y. Author; data collection: Y. Author; analysis and interpretation of results: X. Author, Y. Author. Z. Author; draft manuscript preparation: Y. Author. Z. Author. All authors reviewed the results and approved the final version of the manuscript.

An author name can appear multiple times, and each author name must appear at least once. For single authors, use the following wording: The author confirms sole responsibility for the following: study conception and design, data collection, analysis and interpretation of results, and manuscript preparation.

Acquisition of funding, the collection of data, or general supervision of the research group, by themselves do not justify authorship. Each contributor should have participated sufficiently to take public responsibility for appropriate portions of the manuscript's content. The order of naming the contributors should be based on the relative contribution of the contributor towards the study and writing the manuscript. The author list of any submission should be decided upon and fixed BEFORE submission. Once submitted, the order cannot be changed without the written consent of all the contributors. Please note that electronic signatures or copied and pasted signatures are not acceptable.

Changes to Authorship:

ABR considers the final author list to be complete at the time of the first submission. Please be sure to check that all authors are properly listed on the revision submission; this includes the spelling of an author's name, their designated degrees, and the order of authors listed.

Contribution Details:

Contributors should provide a description of contributions made by each of them towards the manuscript. Description should be divided in following categories, as applicable: concept, design, definition of intellectual content, literature search, clinical studies, experimental studies, data acquisition, data analysis, statistical analysis, manuscript preparation, manuscript editing and manuscript review. One or more author should take responsibility for the integrity of the work as a whole from inception to published article and should be designated as 'guarantor'.

Conflicts of Interest/ Competing Interests

All authors of must disclose any and all conflicts of interest they may have with publication of the manuscript or an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose conflict of interest with products that compete with those mentioned in their manuscript.

Protection of Patients’Right to Privacy

Identifying information should not be published in written descriptions, photographs, sonograms, CT scans, etc., and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian, wherever applicable) gives informed consent for publication. Authors should remove patients' names from figures unless they have obtained informed consent from the patients. The journal abides by ICMJE guidelines:

1) Authors, not the journals nor the publisher, need to obtain the patient consent form before the publication and have the form properly archived. The consent forms are not to be uploaded with the cover letter or sent through email to editorial or publisher offices.

2) If the manuscript contains patient images that preclude anonymity or a description that has an obvious indication of the identity of the patient, a statement about obtaining informed patient consent should be indicated in the manuscript.

Checking for plagiarism, duplicate publication, and text recycling

In the interest of preserving the scientific integrity of all articles published in ABR, starting in January 2012, the Editorial Office will be running all revised manuscripts through an online plagiarism-prevention program. Following the lead of the Committee on Publication Ethics (COPE), whose policies are in turn supported by the ICMJE, if plagiarism is discovered, the author will be notified before any further action is taken. ABR adheres to the process established by COPE, whose guidelines and flowcharts for action are available online at publicationethics.org.

Misconduct

We will energetically pursue accusations of misconduct directed at authors, Editors or referees and have a number of sanctions at our disposal including the option to inform employers about accusations and ask them to mount their own internal investigations. Accusations should not be made lightly or in the absence of the likelihood of supporting evidence being obtainable. The Journal may take the view that accusations are malicious if supporting evidence cannot be found and may direct sanctions against accusers in such cases. Any accusation of misconduct should be addressed to the Editor-in-Chief (unless it involves the Editor-in-Chief, in which case it should be directed to the Chairman of the Advisory Board). ABR is a member of COPE and will follow its guidelines on the handling of investigations into research misconduct.


3- This section provides general style and formatting information only. Formatting guidelines for specific article types can be found in the next section.

General formatting guidelines:

Preparing manuscript text:

  • Use double line spacing
  • Include line and page numbering
  • Use SI units: Please ensure that all special characters used are embedded in the text. Otherwise, they will be lost during conversion to PDF
  • Do not use page breaks in your manuscript

The following word processor file formats are acceptable for the main manuscript document:

  • Microsoft word (DOC, DOCX)

The authors should prepare two separate files for submission:

Title Page:

This file should provide

  1. The type of manuscript (original article, case report, review article, Letter to editor, etc.)
  2. Title of the manuscript
  3. Running title
  4. Names of all authors and their affiliations.
  5. Author/coauthor(s) ORCID iDs are required in the submission process. If you do not have ORCID iDs, please register via https://orcid.org. And after getting the identifiers, please include them in the "first page" file of the manuscript. Further process of your paper in this journal would depend on presenting ORCID iDs.
  6. A statement that the manuscript has been read and approved by all the authors, that the requirements for authorship as stated earlier in this document have been met, and that each author believes that the manuscript represents honest work.
  7. The name, address, e-mail, and telephone number of the corresponding author, who is responsible for communicating with the other authors about revisions and final approval of the proofs, if that information is not included on the manuscript itself.
  8. Total number of pages
  9. Total number of tables
  10. Total number of figures
  11. Word counts separately for abstract and for the text (excluding the references, tables and abstract), word counts for introduction + discussion in case of an original article;
  12. If the manuscript was presented as part at a meeting, the organization, place, and exact date on which it was read. A full statement to the editor about all submissions and previous reports that might be regarded as redundant publication of the same or very similar work. Any such work should be referred to specifically, and referenced in the new paper. Copies of such material should be included with the submitted paper, to help the editor decide how to handle the matter.
  13. The declarations section of the manuscript including all of its subheadings:
  • Ethics approval and consent to participate
  • Consent for publication
  • Availability of data and materials
  • Competing interests
  • Funding
  • Authors' contributions
  • Acknowledgements
  • Authors' information (optional)

Tip: All information that can reveal your identity should be here on the Title page, not the blinded article file.

Blinded Article File:

The title of the manuscript and main text of the manuscript, beginning from Abstract till References (excluding declarations section) should be in this file. The file must not contain any mention of the authors' names.


Declarations:

All manuscripts must contain the following sections under the heading 'Declarations':

Ethics approval and consent to participate

Manuscripts reporting studies involving human participants, human data or human tissue must:

  • include a statement on ethics approval and consent (even where the need for approval was waived)

  • include the name of the ethics committee that approved the study and the committee’s reference number if appropriate

Studies involving animals must include a statement on ethics approval and for experimental studies involving client-owned animals, authors must also include a statement on informed consent from the client or owner.

If your manuscript does not report on or involve the use of any animal or human data or tissue, please state “Not applicable” in this section.

Consent for publication:

If your manuscript contains any individual person’s data in any form (including any individual details, images or videos), consent for publication must be obtained from that person, or in the case of children, their parent, or legal guardian. All presentations of case reports must have consent for publication.

You can use your institutional consent form or Isfahan University of Medical Sciences consent form. You should not send the form to us on submission, but we may request to see a copy at any stage (including after publication).

Availability of data and materials:

All manuscripts must include an ‘Availability of data and materials statement. Data availability statements should include information on where data supporting the results reported in the article can be found including, where applicable, hyperlinks to publicly archived datasets analyzed or generated during the study. By data, we mean the minimal dataset that would be necessary to interpret, replicate and build upon the findings reported in the article. We recognize it is not always possible to share research data publicly, for instance when individual privacy could be compromised, and in such instances, data availability should still be stated in the manuscript along with any conditions for access.

Competing interests:

All authors must disclose any and all conflicts of interest they may have with the publication of the manuscript or an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose conflicts of interest with products that compete with those mentioned in their manuscript.

Funding:

All sources of funding for the research reported should be declared. The role of the funding body in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript should be declared.

Authors' contributions:

Contributors should provide a description of contributions made by each of them towards the manuscript. Description should be divided in following categories, as applicable: concept, design, definition of intellectual content, literature search, clinical studies, experimental studies, data acquisition, data analysis, statistical analysis, manuscript preparation, manuscript editing and manuscript review. One or more author should take responsibility for the integrity of the work as a whole from inception to published article and should be designated as 'guarantor'.

Acknowledgments:

Please acknowledge anyone who contributed towards the article who does not meet the criteria for authorship including anyone who provided professional writing services or materials.

Authors should obtain permission to acknowledge from all those mentioned in the Acknowledgements section.

Authors' information:

This section is optional.

You may choose to use this section to include any relevant information about the author(s) that may aid the reader's interpretation of the article, and understand the standpoint of the author(s). This may include details about the authors' qualifications, current positions they hold at institutions or societies, or any other relevant background information. Please refer to authors using their initials. Note this section should not be used to describe any competing interests.


References:

ABR recommends that references be prepared with a bibliography software package such as EndNote, Mendeley, or Zotero. If references are prepared manually, the authors should check them for completeness and correctness. For this purpose authors may use Web of Scienceexternal_linkPubMed/MEDLINEexternal_link or Google Scholarexternal_link.

Quick Reference Formatting Guide:

References should be numbered consecutively in the order in which they are first mentioned in the text (not in alphabetic order). Identify references in text, tables, and legends by Arabic numerals in superscript with square bracket after the punctuation marks. References cited only in tables or figure legends should be numbered in accordance with the sequence established by the first identification in the text of the particular table or figure. Use the style of the examples below, which are based on the formats used by the NLM in Index Medicus. The titles of journals should be abbreviated according to the style used in Index Medicus. Use the complete name of the journal for non-indexed journals. Avoid using abstracts as references. Information from manuscripts submitted but not accepted should be cited in the text as "unpublished observations" with written permission from the source. Avoid citing a "personal communication" unless it provides essential information not available from a public source, in which case the name of the person and date of communication should be cited in parentheses in the text.
The commonly cited types of references are shown here, for other types of references such as newspaper items please refer to ICMJE Guidelines (http://www.icmje.org or http://www.nlm.nih.gov/bsd/uniform_requirements.html).

Articles in Journals

  1. Standard journal article (for up to six authors): Parija S C, Ravinder PT, Shariff MDetection of hydatid antigen in the fluid samples from hydatid cysts by co-agglutination. Trans. R.Soc. Trop. Med. Hyg.1996; 90:255–256.
  2. Standard journal article (for more than six authors): List the first six contributors followed by et al

Roddy P, Goiri J, Flevaud L, Palma PP, Morote S, Lima N. et al., Field Evaluation of a Rapid Immunochromatographic Assay for Detection of Trypanosoma cruzi Infection by Use of Whole Blood. J. Clin. Microbiol. 2008; 46: 2022-2027.

  1. Volume with supplement: Otranto D, Capelli G, Genchi C: Changing distribution patterns of canine vector borne diseases in Italy: leishmaniosis vs. dirofilariosis.Parasites & Vectors 2009; Suppl 1:S2. 

Books and Other Monographs

  1. Personal author(s): Parija SC. Textbook of Medical Parasitology. 3rd ed. All India Publishers and Distributors. 2008.
  2. Editor(s), compiler(s) as author: Garcia LS, Filarial Nematodes In: Garcia LS (editor) Diagnostic Medical Parasitology ASM press Washington DC 2007: pp 319-356.
  3. Chapter in a book: Nesheim M C. Ascariasis and human nutrition. In Ascariasis and its prevention and control, D. W. T. Crompton, M. C. Nesbemi, and Z. S. Pawlowski (eds.). Taylor and Francis,London, U.K.1989, pp. 87–100.

Electronic Sources as reference

Journal article on the Internet: Parija SC, Khairnar K. Detection of excretory Entamoeba histolytica DNA in the urine, and detection of E. histolytica DNA and lectin antigen in the liver abscess pus for the diagnosis of amoebic liver abscess .BMC Microbiology 2007, 7:41.doi:10.1186/1471-2180-7-41. http://www.biomedcentral.com/1471-2180/7/41

Endnote Users:

If you use Endnote as the reference management tool for your manuscripts, you can download our journal referencing style from the link here.

Simply Extract the file, Open the "Advanced Biomedical Research.ens" file, then go to File > Save As and save the style with the name "Advanced Biomedical Research". After that, you can use this style for your references.


Preparing tables:

When preparing tables, please follow the formatting instructions below.

  • Tables with their legends should be provided at the end of the text after the references. The tables along with their number should be cited at the relevant place in the text
  • Tables should be self-explanatory and should not duplicate textual material.

  • Tables with more than 10 columns and 25 rows are not acceptable.

  • Number tables, in Arabic numerals, consecutively in the order of their first citation in the text and supply a brief title for each.

  • Place explanatory matter in footnotes, not in the heading.

  • Explain in footnotes all non-standard abbreviations that are used in each table.

  • Obtain permission for all fully borrowed, adapted, and modified tables and provide a credit line in the footnote.

  • For footnotes use the following symbols, in this sequence: *, †, ‡, §, ||,¶, **, ††, ‡‡


Preparing illustrations(Figures):

  • Figures with their legends should be provided at the end of the text after the references. The figures along with their number should be cited at the relevant place in the text
  • Upload the images in JPEG format.

  • Figures should be numbered consecutively according to the order in which they have been first cited in the text.

  • Titles and detailed explanations belong in the legends for illustrations not on the illustrations themselves.

  • The photographs and figures should be trimmed to remove all the unwanted areas.

  • If photographs of individuals are used, their pictures must be accompanied by written permission to use the photograph.

  • If a figure has been published elsewhere, acknowledge the original source and submit written permission from the copyright holder to reproduce the material. A credit line should appear in the legend for such figures.

  • Legends for illustrations: Type or print out legends (maximum 40 words, excluding the credit line) for illustrations using double spacing, with Arabic numerals corresponding to the illustrations. When symbols, arrows, numbers, or letters are used to identify parts of the illustrations, identify and explain each one in the legend. Explain the internal scale (magnification) and identify the method of staining in photomicrographs.

  • The Journal reserves the right to crop, rotate, reduce, or enlarge the photographs to an acceptable size.


2- This section provides formatting guidelines for specific article types.

Original Article:

These include randomized controlled trials, intervention studies, studies of screening and diagnostic tests, outcome studies, cost-effectiveness analyses, case-control series, and surveys with high response rates.

Abstract:

The Abstract should not exceed 250 words. Please minimize the use of abbreviations and do not cite references in the abstract. Reports of randomized controlled trials should follow the CONSORT extension for abstracts. The abstract must include the following separate sections:

  • Background: the context and purpose of the study
  • Materials and Methods: how the study was performed and statistical tests used
  • Results: the main findings
  • Conclusions: brief summary and potential implications

Keywords:

Provide 3 to 10 keywords, according to the terms used in the MeSH (Medical Subject Headings) of the Index Medicus/Medline

Introduction:

The Introduction section should explain the background to the study, its aims, a summary of the existing literature and why this study was necessary or its contribution to the field.

Materials and Methods:

The methods section should include:

  • the aim, design, and setting of the study
  • the characteristics of participants or description of materials
  • a clear description of all processes, interventions, and comparisons. Generic drug names should generally be used. When proprietary brands are used in research, include the brand names in parentheses
  • the type of statistical analysis used, including a power calculation if appropriate

Results:

This should include the findings of the study including, if appropriate, results of statistical analysis which must be included either in the text or as tables and figures.

Discussion:

This section should discuss the implications of the findings in the context of existing research and highlight the limitations of the study.

Conclusions:

This should state clearly the main conclusions and provide an explanation of the importance and relevance of the study reported.

Declarations:

All manuscripts must contain the heading 'Declarations' with all of its subheadings. For detailed information about declarations please click here. This section of the manuscript should be on the "Title Page" file, not the "Blinded Article" file.

References:

please see the "References" sub-section under the general formatting guidelines section.

Tables:

please see the "Preparing tables" sub-section under the general formatting guidelines section.

Figures:

please see the "Preparing figures" sub-section under the general formatting guidelines section.


Clinical Trials:

Clinical trials are a sub-category of original articles, so all the formatting guidelines for the original articles are identical to clinical trials. Moreover, If you are carrying out a clinical trial, you must register it in an approved clinical trial registry BEFORE you enroll the first patient.

Registration in the following trial registers is acceptable:

http://www.clinicaltrials.gov

http://www.irct.ir

http://ctri.nic.in

https://www.anzctr.org.au

http://isrctn.org

http://www.trialregister.nl

http://www.umin.ac.jp/ctr

You should include the trial registration number (also known as a clinical trial number) in the abstract of any manuscripts that report the results of that clinical trial.

For clinical trials, the CONSORT checklist must be completed before peer-review and made available to the Editors and reviewers. (Please upload the CONSORT checklist as a supplementary file through our submission platform.) Please check the standards of reporting section for more information.


Review Articles:

It is expected that these articles would be written by individuals who have done substantial work on the subject or are considered experts in the field. A summary of the work done by the contributor(s) in the field of review should accompany the manuscript.

  • The prescribed word count is up to 7000 words, including tables/figures, references, and abstract.
  • The manuscript may have unlimited references.
  • The number of tables and figures is unlimited.
  • The manuscript should have an unstructured Abstract (250 words) representing an accurate article summary.

The manuscript should be divided into sections with these headings:

 

Abstract:

The manuscript should have an unstructured abstract (250 words) representing an accurate article summary.

Keywords:

Provide 3 to 10 keywords, according to the terms used in the MeSH (Medical Subject Headings) of the Index Medicus/Medline

Introduction:

The Background section should explain the background to the article, its aims, a summary of a search of the existing literature, and the issue under discussion.

Main Text:

This should contain the body of the article, and may also be broken into subsections with short, informative headings.

Conclusion:

This should state clearly the main conclusions and include an explanation of their relevance or importance to the field.

Declarations:

All manuscripts must contain the heading 'Declarations' with all of its subheadings. For detailed information about declarations please click here. This section of the manuscript should be on the "Title Page" file, not the "Blinded Article" file.

References:

please see the "References" sub-section under the general formatting guidelines section.

Tables:

please see the "Preparing tables" sub-section under the general formatting guidelines section.

Figures:

please see the "Preparing figures" sub-section under the general formatting guidelines section.

 


Short Reports:

 Short reports provide a brief but complete account of an original piece of work.

Abstract:

The Abstract should not exceed 200 words. Please minimize the use of abbreviations and do not cite references in the abstract. The abstract must include the following separate sections:

  • Background: the context and purpose of the study
  • Materials and Methods: how the study was performed and statistical tests used
  • Results: the main findings
  • Conclusions: brief summary and potential implications

Keywords:

Provide 3 to 5 keywords, according to the terms used in the MeSH (Medical Subject Headings) of the Index Medicus/Medline

Introduction:

The Introduction section should explain the background to the study, its aims, a summary of the existing literature and why this study was necessary or its contribution to the field.

Materials and Methods:

The methods section should include:

  • the aim, design, and setting of the study
  • the characteristics of participants or description of materials
  • a clear description of all processes, interventions, and comparisons. Generic drug names should generally be used. When proprietary brands are used in research, include the brand names in parentheses
  • the type of statistical analysis used, including a power calculation if appropriate

Results:

This should include the findings of the study including, if appropriate, results of statistical analysis which must be included either in the text or as tables and figures.

Discussion:

This section should discuss the implications of the findings in the context of existing research and highlight the limitations of the study.

Conclusions:

This should state clearly the main conclusions and provide an explanation of the importance and relevance of the study reported.

Declarations:

All manuscripts must contain the heading 'Declarations' with all of its subheadings. For detailed information about declarations please click here. This section of the manuscript should be on the "Title Page" file, not the "Blinded Article" file.

References:

please see the "References" sub-section under the general formatting guidelines section.

Tables:

please see the "Preparing tables" sub-section under the general formatting guidelines section.

Figures:

please see the "Preparing figures" sub-section under the general formatting guidelines section.


Case Reports:

New, interesting, and rare cases can be reported. They should be unique, describing a great diagnostic or therapeutic challenge and providing a learning point for the readers. Cases with clinical significance or implications will be given priority.

  • The manuscript could be up to 1000 words (including references and abstract).
  • The manuscript could be supported with up to 15 references.
  • Case Reports could be authored by up to 4 authors.

Any images should protect the patient’s anonymity as far as possible. Any photos or medical imaging should not show the patient's name, medical record number, or date of birth. Images should be cropped only to show the key feature. As per journal policy, ABR does not consider images with patient faces or patient facial features. If an image of a face must be published, this should be cropped so that only the affected area is shown. 

Consent for publication is a mandatory journal requirement for all case reports. Written informed consent for publication must be obtained from the patient (or their parent or legal guardian in the case of children under 18, or from the next of kin if the patient has died). For more information, please see our editorial policies.

For case reports, ABR journal requires authors to follow the CARE guidelines. The CARE checklist should be provided as an additional file. Submissions received without these elements will be returned to the authors as incomplete.

The manuscript should be divided into sections with these headings:

Abstract:

The manuscript should have an unstructured abstract (200 words) representing an accurate article summary.

Keywords:

Provide 3 to 5 keywords, according to the terms used in the MeSH (Medical Subject Headings) of the Index Medicus/Medline

Introduction:

The Introduction section should explain the background to the case report or study, its aims, a summary of the existing literature.

Case Presentation:

This section should include a description of the patient’s relevant demographic details, medical history, symptoms and signs, treatment or intervention, outcomes, and any other significant details.

Discussion:

This should discuss the relevant existing literature.

Conclusion:

This should state clearly the main conclusions, including an explanation of their relevance or importance to the field.

Declarations:

All manuscripts must contain the heading 'Declarations' with all of its subheadings. For detailed information about declarations please click here. This section of the manuscript should be on the "Title Page" file, not the "Blinded Article" file.

References:

please see the "References" sub-section under the general formatting guidelines section.

Tables:

please see the "Preparing tables" sub-section under the general formatting guidelines section.

Figures:

please see the "Preparing figures" sub-section under the general formatting guidelines section.


Letter to Editor:

A Letter to the Editor generally takes one of the following forms:

  • A substantial re-analysis of a previously published article in Advanced Biomedical Research or in another journal.
  • An article that may not cover "standard research" but that is of general interest to the readership of Advanced Biomedical Research.
  • A brief report of research findings adequate for the journal's scope and of particular interest to the community.
  • The letter could have up to 500 words and 7 references.
  • Maximum of one figure or one table
  • Not more than four authors could generally author it.

The manuscript should be divided into sections with these headings:

Keywords:

Provide 3 to 5 keywords, according to the terms used in the MeSH (Medical Subject Headings) of the Index Medicus/Medline

Main Text:

This should contain the body of the article, and may also be broken into subsections with short, informative headings.

Main text should start with "To the editor."

 

Declarations:

All manuscripts must contain the heading 'Declarations' with all of its subheadings. For detailed information about declarations please click here. This section of the manuscript should be on the "Title Page" file, not the "Blinded Article" file.

References:

please see the "References" sub-section under the general formatting guidelines section.

Tables:

please see the "Preparing tables" sub-section under the general formatting guidelines section.

Figures:

please see the "Preparing figures" sub-section under the general formatting guidelines section.



Submit and afterward

1- Submit your manuscript through our online submission platform.

Online Submission:

All manuscripts must be submitted online on our Submission Platform.

First-time Users

Please click the Register as an author button on Submission Platform. Upon registration, you will be sent an email providing your username and password. Save this information for future reference. Note: If you have received an email from us with an assigned username and password, or if you are a repeat user, do not register again. Once you have an assigned username and password, you do not have to re-register.

Authors

Please click the Login button from the menu at the top of the page and log in to the system as an author. Submit your manuscript according to the authors' instructions. You will be able to track the progress of your manuscript through the system.


2- What is the editorial process of the journal and how does ABR decide whether my work will be accepted?

The Editorial Process: 

A manuscript will be reviewed for possible publication with the understanding that it is being submitted to Advanced Biomedical Research Journal alone at that point in time and has not been published anywhere, simultaneously submitted, or already accepted for publication elsewhere. The journal expects that authors would authorize one of them to correspond with the Journal for all matters related to the manuscript. All manuscripts received are duly acknowledged. On submission, editors review all submitted manuscripts initially for suitability for formal review. Manuscripts with insufficient originality, serious scientific or technical flaws or lack of a significant message are rejected before proceeding for formal peer-review. Manuscripts that are unlikely to be of interest to the ABR readers are also liable to be rejected at this stage itself.

Manuscripts received from Editorial Board members will be screened by the Editor in Chief and sent to external peer reviewers. The editorial board members who are authors will be excluded from publication decisions.

Manuscripts that are found suitable for publication in ABR are sent to two or more expert reviewers. The journal follows a double-blind review process, wherein the reviewers and authors are unaware of each other’s identity. Every manuscript is also assigned to a member of the editorial team, who based on the comments from the reviewers takes a final decision on the manuscript. The comments and suggestions (acceptance/ rejection/ amendments in manuscript) received from reviewers are conveyed to the corresponding author. If required, the author is requested to provide a point by point response to reviewers’ comments and submit a revised version of the manuscript. This process is repeated till reviewers and editors are satisfied with the manuscript.

Manuscripts accepted for publication are copy edited for grammar, punctuation, print style, and format. Page proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within three days. It may not be possible to incorporate corrections received after that period. The whole process of submission of the manuscript to final decision and sending and receiving proofs is completed online.

Processes for appeals 

The authors do have the right to appeal if they have a genuine cause to believe that the editorial board has wrongly rejected the paper. If the authors wish to appeal the decision, they should email the editorial office (email: [email protected]) explaining in detail the reason for the appeal. The appeals will be acknowledged by the editorial office and will be investigated in an unbiased manner. The processing of appeals will be done within 6 – 8 weeks. While under appeal, the said manuscript should not be submitted to other journals. The final decision rests with the Editor in Chief of the journal. Second appeals are not considered.

Anti-Plagiarism Policy

Plagiarism includes duplicate publication of the author’s own work, in whole or in part without proper citation or mispresenting other’s ideas, words, and other creative expression as one’s own. The Journal follows strict anti-plagiarism policy. All manuscripts submitted to Sahel Medical Journal undergoes plagiarism check with commercially available software. Based on the extent of plagiarism, authors may be asked to address any minor duplication, or similarity with the previous published work. If plagiarism is detected after publication, the Journal will investigate. If plagiarism is established, the journal will notify the authors’ institution and funding bodies and will retract the plagiarised article. To report plagiarism, contact the journal office (email: [email protected]). 

Peer-Review Policy:

Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity, and significance to help editors determine whether the manuscript should be published in their journal.

When a manuscript is submitted to ABR, it is assessed to see if it meets the criteria for submission. If it does, the editorial team will select potential peer reviewers within the field of research to peer-review the manuscript and make recommendations.

Double-blind peer review used by ABR. In this type of peer-review the reviewers do not know the names of the authors, and the authors do not know who reviewed their manuscript. If you have shared an earlier version of your Author’s Original Manuscript on a preprint server, please be aware that anonymity cannot be guaranteed. 

Manuscripts submitted to ABR are assessed by our editors and/or peer reviewers. Overall editorial responsibility for the journal is with the Editor. 

Contributors Form

Download Template for Original Articles/ABSTRACT Reports. (.DOT file)

Download Letter to the Editor. (.DOT file)


Top

 
Feedback
Subscribe
What's New
Reference style (PPS)
Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal